LEXINGTON, Mass.--(BUSINESS WIRE)--N-of-One, Inc., the leader in clinical interpretation for precision medicine in oncology, today announced the appointment of two senior executives to support the company’s rapid growth. The market for N-of-One’s clinical interpretation is exploding, as evidenced by the significant number of new contracts N-of-One signed with major diagnostics companies and leading cancer centers in the past 12 months. In order to proactively support current and prospective clients’ evolving needs in precision medicine, the company has created two new positions: Vice President of Sales and Vice President of Operations.
Mark Balsano joins N-of-One in the newly created position of Vice President of Sales. Previously, Mark was Vice President of Sales at Response Genetics. Mark is an experienced sales leader in clinical diagnostics and diagnostic testing and has a successful track record in building a world-class sales team. Mark will leverage his experience to build out the commercial team at N-of-One to support the growing demand from cancer centers and diagnostics companies. He will be working closely with current N-of-One customers as well as new health networks and diagnostic labs interested in N-of-One solutions and services.
Dave Stowell joins N-of-One in the newly created position of Vice President of Operations. Previously, Dave was Senior Vice President of Client Services for Optum and, prior to that, Dave was at Picis, a high acuity EMR company, as Senior Vice President of Client Management and Client Operations. Dave brings many years of operational experience in healthcare, and has the skills and experience to grow our team to meet market demand. At N-of-One, Dave will lead our daily operations, product management, solution implementation, and ongoing client management and support.
“We are very excited to welcome Mark and Dave as they bring a tremendous level of experience and expertise to the N-of-One team that will significantly extend our ability to address the growing number of global inquiries for our services as well as meet our customers’ needs today and in the future, ” said Chris Cournoyer, CEO of N-of-One. “We now have a team in place that can proactively support clients’ current needs as well as the evolution of their precision medicine programs.”
About N-of-One
N-of-One,
a leader in enabling precision medicine for oncology, leverages its
world-class team of experts coupled with a highly proprietary platform
that allows us to provide clinical solutions and services , such as
molecular interpretation, to clinicians at the point of care. N-of-One’s
team of experts has interpreted thousands of samples for oncologists and
patients worldwide, through partnerships with leading diagnostic
companies, hospital systems, directly to oncologists and through
employee access benefit programs. N-of-One does not provide medical
advice or promote any product or service. For more information, please
visit www.n-of-one.com
or call 617-202-9808.
